Mohiuddin, T.M.; Sheng, W.; Zhang, C.; Al-Rawe, M.; Tchaikovski, S.; Zeppernick, F.; Meinhold-Heerlein, I.; Hussain, A.F.
Multiplex Immunofluorescence Reveals Therapeutic Targets EGFR, EpCAM, Tissue Factor, and TROP2 in Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2025, 26, 7430.
https://doi.org/10.3390/ijms26157430
AMA Style
Mohiuddin TM, Sheng W, Zhang C, Al-Rawe M, Tchaikovski S, Zeppernick F, Meinhold-Heerlein I, Hussain AF.
Multiplex Immunofluorescence Reveals Therapeutic Targets EGFR, EpCAM, Tissue Factor, and TROP2 in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2025; 26(15):7430.
https://doi.org/10.3390/ijms26157430
Chicago/Turabian Style
Mohiuddin, T. M., Wenjie Sheng, Chaoyu Zhang, Marwah Al-Rawe, Svetlana Tchaikovski, Felix Zeppernick, Ivo Meinhold-Heerlein, and Ahmad Fawzi Hussain.
2025. "Multiplex Immunofluorescence Reveals Therapeutic Targets EGFR, EpCAM, Tissue Factor, and TROP2 in Triple-Negative Breast Cancer" International Journal of Molecular Sciences 26, no. 15: 7430.
https://doi.org/10.3390/ijms26157430
APA Style
Mohiuddin, T. M., Sheng, W., Zhang, C., Al-Rawe, M., Tchaikovski, S., Zeppernick, F., Meinhold-Heerlein, I., & Hussain, A. F.
(2025). Multiplex Immunofluorescence Reveals Therapeutic Targets EGFR, EpCAM, Tissue Factor, and TROP2 in Triple-Negative Breast Cancer. International Journal of Molecular Sciences, 26(15), 7430.
https://doi.org/10.3390/ijms26157430
